Ata Fateen, Akkam Veettil Safna Farsana, Gaber Mohammed, Omar Nabil E, Madani Ammar, Mah Afifi Hebatalla, Aldardouri Meeloud M, Amer Aliaa, Kohla Samah, Zar Gul Abdul Rehman
Department of Internal Medicine Hamad General Hospital Hamad Medical Corporation Doha Qatar.
Department of Oncology National Center for Cancer Care & Research Hamad Medical Corporation Doha Qatar.
Clin Case Rep. 2021 Jan 28;9(3):1641-1646. doi: 10.1002/ccr3.3860. eCollection 2021 Mar.
When seeing patients on Temozolomide with pancytopenia, aplastic anemia secondary to the drug should be considered early in the differentials to avoid permanent hematological suppression.
当诊治使用替莫唑胺后出现全血细胞减少的患者时,在鉴别诊断中应尽早考虑药物继发的再生障碍性贫血,以避免永久性血液学抑制。